Provided by Tiger Fintech (Singapore) Pte. Ltd.

Loews

89.27
+0.87000.98%
Pre-market: 87.77-1.5000-1.68%04:12 EDT
Volume:622.52K
Turnover:55.33M
Market Cap:18.72B
PE:14.67
High:89.81
Open:88.88
Low:87.22
Close:88.40
Loading ...

Loews Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
31 Dec 2024

BeiGene Stomach-Cancer Treatment Gets FDA Approval, Second in U.S.

Dow Jones
·
27 Dec 2024

Loews Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
27 Dec 2024

Football: Late Vietnam goals sink Singapore in first leg of ASEAN Championship semis

CNA
·
26 Dec 2024

OKI and FPT Announce Capital and Business Alliance to Strengthen Global Strategic Partnership

Business Wire
·
26 Dec 2024

Loews Corp. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
24 Dec 2024

Loews Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
20 Dec 2024

MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings

Business Wire
·
19 Dec 2024

Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025

GlobeNewswire
·
18 Dec 2024

Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)

GlobeNewswire
·
17 Dec 2024

Loews Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
17 Dec 2024

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas

Business Wire
·
16 Dec 2024

Loews Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
14 Dec 2024

Candel Therapeutics Announces CAN-2409 Achieved Primary Endpoint in Phase 3 Prostate Cancer Trial, Showing Significantly Improved Disease-Free Survival

GlobeNewswire
·
11 Dec 2024

Loews Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
11 Dec 2024

Loews Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
10 Dec 2024

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients

GlobeNewswire
·
09 Dec 2024

Loews Corp. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
07 Dec 2024

Loews Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
05 Dec 2024

IN FOCUS: Can China’s pension system survive the pressure of its ageing population?

CNA
·
04 Dec 2024